Autoimmune hemolytic anemia in patients with non-Hodgkin's lymphoma: Characteristics and significance

Annals of Oncology

Volumn 11, Issue 12, 2000, Pages 1571-1577

  Sallah, S ^a   Sigounas, G ^b   Vos, P ^b   Wan, J Y ^a   Nguyen, N P ^c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c SOUTHWESTERN UNIVERSITY   (United States)

Author keywords

Autoimmune hemolytic anemia; Non Hodgkin's lymphoma; Treatment

Indexed keywords

ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RECEPTOR GENE; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; ANEMIA, HEMOLYTIC, AUTOIMMUNE; COHORT STUDIES; FEMALE; HUMANS; IMMUNOGLOBULINS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0034487508     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008319532359     Document Type: Article

References (26)

1. Autoimmune hemolytic anemia
2. Angioimmunoblastic lymphadenopathy with dysproteinemia: Emphasis on pathogenesis and treatment
3. The role of clonal selection in the pathogenesis of an autoreactive human B-cell lymphoma
4. CD5 and immunoglobulin V gene expression in B-cell lymphomas and chronic lymphocytic leukemia
5. Identification of normal B-cell counterparts of neoplastic cells which secrete cold agglutinins of anti-1 and anti-i specificity
6. H gene and CD5 antigen expression
7. Autoimmune phenomena in non-Hodgkin's lymphoma
8. Autoimmunity and auto-immune syndromes associated with and preceeding the development of lymphoproliferative disorders
9. Report of the committee on Hodgkin's disease staging classification
10. Gamma/delta T-cell hepatosplenic lymphoma: Review of the literature, diagnosis by flow cytometry and concomitant autoimmune hemolytic anemia
11. Autoimmunity in chronic lymphocytic leukemia
12. B-cell chronic lymphocytic leukemia: Present status and future directions
13. The role of 2-chlorodeoxyadenosine in the treatment of patients with refractory angioimmunoblostic lymphadenopathy with dysproteinemia
14. Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies
15. Antibodies against factor VIII in patients with solid tumors: Successful treatment of cancer may suppress inhibitor formation
16. Insight into Burkitt' s lymphoma from immunoglobulin variable region gene analysis
17. Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases
18. Immunoglobulon V gene expression in CD5 B-cell malignancies
19. Somatic mutations and intraclonal variations in the rearranged V Kappa genes of B-non-Hodgkin's lymphoma cell lines
20. VH restriction among human cold agglutinins. The VH 4-21 gene segment is required to encode anti-I and anti-i specificities
21. Biology of the neoplastic lymphocytes in B-CLL
22. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity
23. How B and T cells talk to each other
24. CD 5 + B-cell networks
25. T-cell lymphomas: Immunologic, histologic, clinical and therapeutic analysis of 63 cases
26. Clinical and phenotypic diversity of T-cell lymphomas